Komori
General Meetings of Shareholders4594BrightPath Biotherapeutics Co.,Ltd.Pharmaceuticals

Notice of Convocation of the 23rd Ordinary General Meeting of Shareholders and Meeting Materials

The notice of convocation and meeting materials were disclosed for the 23rd Annual General Meeting of Shareholders, to be held on 25 June 2026. No matters for resolution will be presented this time; the meeting will only report on the business report and financial statements.

Worth reading
34Immaterial
Scored from 3 of 4 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (23rd)
2026
Jun 25
Date and time22 days from this disclosure to the meeting
Matters for resolution1 item
  1. None (Reporting matters: Report on the business report and financial statements for the 23rd fiscal year, from 1 April 2025 to 31 March 2026)

Shareholder Proposal

None (Although the document states that there are no matters for resolution, whether there are shareholder proposals is Not disclosed)

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (23rd)
Date and time10:00 a.m., Thursday, 25 June 2026
Matters for resolutionNone (Reporting matters: Report on the business report and financial statements for the 23rd fiscal year, from 1 April 2025 to 31 March 2026)
Shareholder ProposalNone (Although the document states that there are no matters for resolution, whether there are shareholder proposals is Not disclosed)
Items this document does not state (2)
Director nomineePercentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The document explains that an attendance form, rather than a voting rights exercise form, will be sent because there are no matters for resolution.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 23rd Ordinary General Meeting of Shareholders and Meeting Materials | BrightPath Biotherapeutics Co.,Ltd. (4594) timely disclosure | Komori